首页> 外文期刊>Open Journal of Dentistry and Oral Medicine >Prognostic Validity of AgNOR in Pleomorphic Adenoma
【24h】

Prognostic Validity of AgNOR in Pleomorphic Adenoma

机译:AgNOR在亚型腺瘤中的预后有效性

获取原文
           

摘要

Since the argyrophilic nucleolar organizer region (AgNOR) technique has successfully distinguished various grades of malignancies and enabled prognostic assessment, this paper traces its prognostic validity in predicting the behavior of pleomorphic adenoma (PA). Ten cases of recurrent PAs were compared, on the one hand, where AgNOR score of area fraction was measured before and after recurrence. The same findings were contrasted to ten cases of normal glandular mucosa. Diagnosing both pleomorphic adenomas was based on clinical and histological records of the archival submitted cases. The data were statistically analyzed by t-test, ANOVA, Tukey and Pearson's tests. The study concludes that AgNOR score lack the prognostic validity on testing PA, in terms of distinguishing and or predicting recurrence.
机译:由于嗜银核仁组织者区域(AgNOR)技术已经成功区分了各种级别的恶性肿瘤并启用了预后评估,因此本文追踪了其在预测多形性腺瘤(PA)行为方面的预后有效性。一方面,比较了10例复发性PA患者,其中在复发前后分别测量了AgNOR面积分数。与十例正常的腺粘膜形成对比。根据档案提交病例的临床和组织学记录诊断两种多形性腺瘤。通过t检验,ANOVA,Tukey和Pearson检验对数据进行统计分析。该研究得出结论,就区分或预测复发而言,AgNOR评分缺乏测试PA的预后有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号